First Trust NYSE Arca Biotechnology Index Fund
98 hedge funds and large institutions have $949M invested in First Trust NYSE Arca Biotechnology Index Fund in 2014 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 44 increasing their positions, 31 reducing their positions, and 8 closing their positions.
63% more first-time investments, than exits
New positions opened: 13 | Existing positions closed: 8
50% more funds holding in top 10
Funds holding in top 10: 2 → 3 (+1)
42% more repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 31
20% more capital invested
Capital invested by funds: $794M → $949M (+$155M)
5% more funds holding
Funds holding: 93 → 98 (+5)
2.44% more ownership
Funds ownership: 55.55% → 57.99% (+2.4%)
41% less call options, than puts
Call options by funds: $1.3M | Put options by funds: $2.22M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
+$50.2M |
| 2 |
Wells Fargo
San Francisco,
California
|
+$11.5M |
| 3 |
Morgan Stanley
New York
|
+$11.1M |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$6.47M |
| 5 |
U
UBS
Zurich,
Switzerland
|
+$3.31M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RIG
RiverFront Investment Group
Richmond,
Virginia
|
-$22.8M |
| 2 |
IAS
IMA Advisory Services
Denver,
Colorado
|
-$3.53M |
| 3 |
BTS
BB&T Securities
Richmond,
Virginia
|
-$2.1M |
| 4 |
SG Americas Securities
New York
|
-$1.37M |
| 5 |
Goldman Sachs
New York
|
-$860K |
FBT Hedge Fund Activity: Q3 2014 in Review
98 of the 3,447 institutional investors tracked by Wall St. Rank reported a position in First Trust NYSE Arca Biotechnology Index Fund (FBT) for Q3 2014, worth a combined $949M — up 20% from $794M a quarter earlier.
Buyers outnumbered sellers: 13 funds opened new FBT positions and 8 closed out — a net gain of 5 holders — while 44 added to existing stakes and 31 trimmed.
The largest buyer was First Trust Advisors, adding an estimated $50.2M. The largest seller was RiverFront Investment Group, cutting an estimated $22.8M.
- 98 institutional investors held First Trust NYSE Arca Biotechnology Index Fund (FBT) as of Q3 2014, up from 93 in Q2 2014.
- Funds reported $949M of First Trust NYSE Arca Biotechnology Index Fund stock for Q3 2014, up 20% quarter-over-quarter.
- 13 funds opened new First Trust NYSE Arca Biotechnology Index Fund positions in Q3 2014 and 8 closed out, a net change of +5 holders.
- The largest First Trust NYSE Arca Biotechnology Index Fund buyer in Q3 2014 was First Trust Advisors, an estimated $50.2M added.
- The largest First Trust NYSE Arca Biotechnology Index Fund seller in Q3 2014 was RiverFront Investment Group, an estimated $22.8M sold.
Based on aggregated 13F filings for Q3 2014.